Blake Aftab - 12 Oct 2021 Form 3/A - Amendment Insider Report for Adicet Bio, Inc. (ACET)

Role
Chief Scientific Officer
Signature
/s/ Nick Harvey, as Attorney-in-Fact
Issuer symbol
ACET
Transactions as of
12 Oct 2021
Net transactions value
$0
Form type
3/A - Amendment
Filing time
14 Oct 2021, 17:15:15 UTC
Date Of Original Report
13 Oct 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACET Stock Option (Right to Buy) 12 Oct 2021 Common Stock 50,000 $15.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares shall vest on the first anniversary of April 5, 2021 (the "Vesting Commencement Date") and as to the remaining 75% of such shares in thirty-six (36) equal monthly installments following the first anniversary of the Vesting Commencement Date; provided that the option holder remains continuously engaged by the Company on each such date.

Remarks:

This Form 3/A is being filed to include Exhibit 24, a Power of Attorney for the Reporting Person, which was inadvertently omitted from the original Form 3 filing on October 13, 2021. Exhibit: Power of Attorney